enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.79% | 46.22% | 14.52% | 40.02% | 19.55% |
| Total Depreciation and Amortization | -8.33% | -77.69% | 1.64% | -4.10% | -6.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.44% | -72.49% | -39.17% | -36.97% | -27.08% |
| Change in Net Operating Assets | 192.29% | -129.94% | 94.40% | -302.99% | -391.67% |
| Cash from Operations | 27.64% | 4.47% | 19.41% | 32.56% | -2.71% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -25.09% | 29.71% | -46.74% | 137.84% | -41.39% |
| Cash from Investing | -25.09% | 29.94% | -46.74% | 137.83% | -41.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -22.41% | -- | -- | -- | -98.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.41% | -- | -- | -- | -98.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.80% | 127.32% | -139.56% | 109.41% | -103.22% |